mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.2 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |